Jaundice pp 351-366 | Cite as

Nonsteroid Drug-Induced Cholestasis and Experimental Cholestasis

  • Gabriel L. Plaa
Part of the Hepatology book series (H, volume 2)


While chemically induced hepatotoxic reactions appeared in the medical literature of the early 1900’s, it can be said that the problem of drug-induced cholestasis is a relatively recent occurrence. Its emergence as a distinct clinical problem arises from the time of the introduction of chlorpromazine as a therapeutic agent. Since this time, a number of other nonsteroid drugs have been shown to possess this property (Table I). It can be seen that while certain classes of pharmacologic agents have been associated with this adverse response, chemical similarities between all of the substances are really lacking. In addition to the drugs listed in Table I, certain steroids have been associated with cholestatic reactions in man; among these drugs one finds several anabolic steroids and the oral contraceptives. While the production of liver injury in man by drugs or other chemicals is not a new phenomenon, one can say that the cholestatic reactions produced by these drugs were largely unexpected and unpredictable from their known effects in laboratory animals.


Anabolic Steroid Bile Flow Microsomal Enzyme Intrahepatic Cholestasis Toxic Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    ZBINDEN G: Progress in Toxicology. Special Topics.New York, Springer-Verlag, 1974. p. 18.Google Scholar
  2. 2.
    IMAI K, HAYASHI Y: Steroid-induced intrahepatic cholestasis in mice. Japan J Pharmacol 20: 473–481, 1970.CrossRefGoogle Scholar
  3. 3.
    PLAA GL: Hyperbilirubinemia and cholestasis, a different form of liver injury produced in animals. In Essays in Toxicology, vol. 2. Edited by Blood, F. New York, Academic Press, 1970. pp. 137–154.Google Scholar
  4. 4.
    INDACOCHEA-REDMOND N, PLAA GL: Functional effects of -naphthylisothiocyanate in various species. Toxicol Appl Pharmacol 19: 71–80, 1971.PubMedCrossRefGoogle Scholar
  5. 5.
    ROBERTS RJ, PLAA GL: Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by naphthylisothiocyanate. J Pharmacol Exp Ther 155: 330–336, 1967.Google Scholar
  6. 6.
    INDACOCHEA-REDMOND N, WITSCHI HP, PLAA GL: Effects of inhibitors of protein and ribonucleic acid synthesis on naphthylisothiocyanate-induced hyperbilirubinemia, sulfobromophthalein retention and prolongation of pentobarbital hypnosis. J Pharmacol Exp Ther 189: 278–284, 1974.PubMedGoogle Scholar
  7. 7.
    PLAA GL, ROGERS LA, FOUTS JR: Effect of acute alpha-naphthyl-isothiocyanate administration on hepatic microsomal drug metabolism in the mouse. Proc Soc Exp Biol Med 119: 1045–1048, 1965.PubMedGoogle Scholar
  8. 8.
    ROBERTS RJ, PLAA GL: Alteration in biliary bilirubin content and nonerytropoietically derived bilirubin synthesis in rats after naphthylisothiocyanate administration. J Pharmacol Exp Ther 161: 382–388, 1968.PubMedGoogle Scholar
  9. 9.
    INDACOCHEA-REDMOND N, WITSCHI HP, PLAA GL: Effect of inhibitors of protein and ribonucleic acid synthesis on the hyperbilirubinemia and cholestasis produced by naphthylisothiocyanate. J Pharmacol Exp Ther 184: 780–786, 1973.PubMedGoogle Scholar
  10. 10.
    TRAIGER GJ, DE REPENTIGNY L, PLAA GL: Effect of inhibitors of protein and ribonucleic acid synthesis on the alteration in biliary bilirubin excretion and non-erythropoi-etically derived bilirubin synthesis in rats after naphthylisothiocyanate administration. Biochem Pharmacol (in press)Google Scholar
  11. 11.
    ROBERTS RJ, PLAA GL: Potentiation and inhibition of naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. J Pharmacol Exp Ther 150: 499–506, 1965.PubMedGoogle Scholar
  12. 12.
    ROBERTS RJ, PLAA GL: Effect of norethandrolone, aceto-hexamide, and Enovid on naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. Biochem Pharmacol 15: 333–341, 1966.PubMedCrossRefGoogle Scholar
  13. 13.
    SELYE H: Hormones and Resistance, vol. 1. New York, Springer-Verlag, 1974. p 273.Google Scholar
  14. 14.
    INDACOCHEA-REDMOND N, PLAA GL: Effect of 16--pregnenolone carbonitrile (PCN) on naphthylisothiocyanate (ANIT)-induced hepatotoxicity. Proc Can Fed Biol Soc 17: 53, 1974.Google Scholar
  15. 15.
    TRAIGER GJ, PLAA GL: Differences in the potentiation of carbon tetrachloride in rats by ethanol and isopropanol pretreatment. Toxicol Appl Pharmacol 20: 105–112, 1971.PubMedCrossRefGoogle Scholar
  16. 16.
    TRAIGER GJ, PLAA GL: Relationship of alcohol metabolism to the potentiation of CCl4 hepatotoxicity induced by aliphatic alcohols. J Pharmacol Exp Ther 183: 481–488, 1972.PubMedGoogle Scholar
  17. 17.
    PLAA GL, TRAIGER GJ, HANASONO GK, WITSCHI HP: Effect of alcohols on various forms of chemically induced liver injury. In Alcholic Liver Pathology, edited by Israel Y, Khanna J, Kalant H. Toronto, Addiction Research Foundation (in press).Google Scholar
  18. 18.
    WITZLEBEN CL, PITLICK P, BERGMEYER J, et al. Acute manganese overload. A new experijiiental model of intrahepatic cholestasis. Amer J Pathol 53: 409–423, 1968.Google Scholar
  19. 19.
    BOYCE W, WITZLEBEN CL: Bilirubin as a cholestatic agent. II. Effect of variable doses of bilirubin on the severity of manganese-bilirubin cholestasis. Amer J Pathol 72: 427–432, 1973.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Gabriel L. Plaa
    • 1
  1. 1.Université de MontréalMontréalCanada

Personalised recommendations